Search
Filters
Clear All
  • 17
  • 49
  • 2
  • 652

Phase

  • 1
  • 11
  • 13
  • 49
  • 7
  • 68
  • 6
  • 539
  • 655
  • 304

Found 720 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

B
Brian Weiss
12-39 years
All genders
Phase 2
Interventional
What is the purpose of this study?This phase II trial studies the effects of trastuzumab deruxtecan in treating patients with HER2 positive osteosarcoma that is newly diagnosed or has come back (recurrent). Trastuzumab deruxtecan is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug called deruxtecan. Trastuzumab attaches to …
Learn More
S
Sandeep Batra, MD
2-25 years
All genders
Phase 3
Interventional
What is the purpose of this study?This phase III trial investigates the best dose of vinblastine in combination withumetinib and the benefit of adding vinblastine to selumetinib compared to selumetinibg children and young adults with low-grade glioma (a common type of brain) that has come back after prior treatment (recurrent) …
Learn More
S
Sandeep Batra, MD
24-18 years
All genders
Phase 2
Interventional
What is the purpose of this study?This trial studies the side effects of enasidenib and to see how well it works in treatingwith acute myeloid leukemia that has come back after treatment (relapsed) or has been difficult to treat with chemotherapy (refractory). Patients must also have a specific genetic change, …
Learn More
N
Nabil Adra, MD
18 years and older
All genders
Phase 2
Interventional
What is the purpose of this study?This is an open label randomized phase II trial of maintenance oral etoposide vs. observationwith relapsed GCT treated with high-dose chemotherapy (HDCT) and peripheral-blood(PBSCT).THIS STUDY IS ENROLLING BY INVITATION ONLY - Consistent with most oncology trials, patients are not actively “recruited,” but are screened …
Learn More
M
Marissa Just
30 years and younger
All genders
Phase 2
Interventional
What is the purpose of this study?This phase II trial studies how well combination chemotherapy works in treating patients withwly diagnosed stage II-IV diffuse anaplastic Wilms tumors (DAWT) or favorable histology Wilms tumors (FHWT) that have come back (relapsed). Drugs used in chemotherapy regimens suchH-3 (vincristine, doxorubicin, cyclophosphamide, carboplatin, etoposide, …
Learn More
F
Francesca Duncan
50-80 years
All genders
Interventional
Lung cancer is the leading cause of cancer death in the United States among men and women. Lung cancer screening using low-dose CT scan can identify lung cancer at its’ earliest stage when more curative treatment options are available. However, only 4-6% of people eligible for lung cancer screening get …
Learn More
S
Sandeep Batra, MD
2-21 years
All genders
Phase 3
Interventional
What is the purpose of this study?This phase III trial compares the effect of selumetinib versus the standard of care treatment with carboplatin and vincristine (CV) in treating patients with newly diagnosed or previously untreated low-grade glioma (LGG) that does not have a genetic abnormality called BRAFV600Eutation and is not …
Learn More
S
Sandeep Batra, MD
1-25 years
All genders
Phase 3
Interventional
What is the purpose of this study?This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia (B-ALL) improves outcomes. This trial also studies the outcomes of patients with mixed phenotype acute leukemia (MPAL), and B-lymphoblastic lymphoma (B-LLy) when treated with …
Learn More
N
Noah Parker, MD
22-100 years
All genders
Interventional
What is this study about?The objective of this early feasibility study is to assess the safety of chronic dual site stimulation by adding infrahyoid stimulation in non-responding patients with pre-existing single-site hypoglossal nerve stimulation.This study will also assess whether the secondary Inspire System can achieve the intended purpose of causing …
Learn More
K
Kirsten Kloepfer, MD
6-57 years
All genders
Phase 3
Interventional
What is this study about?This is an extension study to evaluate the long-term safety and efficacy of ligelizumab in participants who have completed a ligelizumab Phase III study in food allergy.THIS STUDY IS ENROLLING BY INVITATION ONLY - the research team will directly contact participants who have completed the treatment …
Learn More
51 - 60 of 720